{"id":"https://openalex.org/W53393368","doi":null,"title":"Abstract 17765: A Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Healthy Male Volunteers","display_name":"Abstract 17765: A Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Healthy Male Volunteers","publication_year":2013,"publication_date":"2013-11-26","ids":{"openalex":"https://openalex.org/W53393368","mag":"53393368"},"language":"en","primary_location":{"id":"mag:53393368","doi":null,"is_oa":false,"landing_page_url":"https://www.ahajournals.org/doi/10.1161/circ.128.suppl_22.A17765","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Circulation","raw_type":null},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041656388","display_name":"Stephan Glund","orcid":"https://orcid.org/0000-0003-4582-3679","observed_orcids":["https://orcid.org/0000-0003-4582-3679"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephan Glund","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4582-3679","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002133662","display_name":"Joachim Stangier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joachim Stangier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064348773","display_name":"Michael Schmohl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Schmohl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110170609","display_name":"Marina De Smet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina De Smet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056192984","display_name":"Dietmar Gan\u00dfer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dietmar Gan\u00dfer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101503711","display_name":"Benjamin\u00a0J. Lang","orcid":"https://orcid.org/0000-0002-2205-8591","observed_orcids":["https://orcid.org/0000-0002-2205-8591","https://orcid.org/0000-0002-1584-6194"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Lang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2205-8591","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034335522","display_name":"Viktoria Moschetti","orcid":"https://orcid.org/0000-0001-7632-2397","observed_orcids":["https://orcid.org/0000-0001-7632-2397"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Viktoria Moschetti","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7632-2397","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022587039","display_name":"Steven Ramael","orcid":"https://orcid.org/0000-0002-5920-7191","observed_orcids":["https://orcid.org/0000-0002-5920-7191"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Ramael","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5920-7191","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110573364","display_name":"Paul A. Reilly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Reilly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"128","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.8163999915122986,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.8163999915122986,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.14970000088214874,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":0.9900000095367432},{"id":"https://openalex.org/keywords/antidotes","display_name":"antidotes","score":0.859000027179718},{"id":"https://openalex.org/keywords/fab-antibody-fragments","display_name":"antibody Fab fragment","score":0.7860000133514404},{"id":"https://openalex.org/keywords/anticoagulation-reversal","display_name":"anticoagulant reversal","score":0.7710000276565552},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.8619999885559082},{"id":"https://openalex.org/keywords/thrombin-inhibition","display_name":"thrombin inhibition","score":0.925000011920929},{"id":"https://openalex.org/keywords/hemorrhage-control","display_name":"hemorrhage control","score":0.6330000162124634},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9459999799728394},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9869999885559082},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.9838560819625854},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9315834045410156},{"id":"https://openalex.org/C2776710957","wikidata":"https://www.wikidata.org/wiki/Q5280395","display_name":"Direct thrombin inhibitor","level":5,"score":0.6203271746635437},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.595413088798523},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5881565809249878},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5880094170570374},{"id":"https://openalex.org/C2776413415","wikidata":"https://www.wikidata.org/wiki/Q17630273","display_name":"Idarucizumab","level":5,"score":0.5738465785980225},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5424604415893555},{"id":"https://openalex.org/C2779365888","wikidata":"https://www.wikidata.org/wiki/Q194168","display_name":"Antidote","level":3,"score":0.5378178358078003},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.513659656047821},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.49860501289367676},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.465071439743042},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.45077985525131226},{"id":"https://openalex.org/C2777091921","wikidata":"https://www.wikidata.org/wiki/Q2044524","display_name":"Prothrombin complex concentrate","level":4,"score":0.43792232871055603},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23590853810310364},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2211635410785675},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.15787896513938904},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.07226452231407166},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06081289052963257},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:53393368","doi":null,"is_oa":false,"landing_page_url":"https://www.ahajournals.org/doi/10.1161/circ.128.suppl_22.A17765","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Circulation","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2613998341","https://openalex.org/W2894541987","https://openalex.org/W2550607242","https://openalex.org/W2069150111","https://openalex.org/W2979863292","https://openalex.org/W2614441898","https://openalex.org/W2136695943","https://openalex.org/W2108742851","https://openalex.org/W1971941179","https://openalex.org/W1837856599"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1],"new":[2],"oral":[3],"anticoagulants":[4],"are":[5,13],"effective":[6],"alternatives":[7],"for":[8,17,143],"warfarin":[9],"but":[10],"specific":[11,31],"antidotes":[12],"not":[14],"yet":[15],"available":[16],"these":[18],"agents":[19],"to":[20,111],"manage":[21],"life-threatening":[22],"bleeding":[23],"or":[24],"when":[25],"emergency":[26],"surgery":[27],"is":[28,35],"necessary.":[29],"A":[30],"antibody":[32],"fragment":[33],"(Fab)":[34],"being":[36],"developed":[37],"which":[38],"binds":[39],"dabigatran":[40,47,139,149],"with":[41],"high":[42],"affinity":[43],"and":[44,77,125],"thereby":[45],"prevents":[46],"inhibition":[48],"of":[49,63,70,80,100,109,120,138,147,155],"thrombin.":[50],"For":[51],"the":[52,67,81,101,136],"first":[53],"time":[54],"in":[55,85,92,135],"human":[56],"volunteers,":[57],"we":[58],"determined":[59,151],"whether":[60],"equimolar":[61],"doses":[62,108,119],"Fab":[64,82,118],"would":[65],"reverse":[66],"anticoagulant":[68],"effects":[69],"dabigatran.":[71],"METHODS:":[72],"Safety,":[73],"tolerability,":[74],"pharmacokinetics":[75],"(PK)":[76],"pharmacodynamics":[78],"(PD)":[79],"were":[83,128,150],"investigated":[84],"a":[86,153],"randomized,":[87],"double-blind,":[88],"placebo":[89],"controlled":[90],"study":[91],"145":[93],"healthy":[94],"male":[95],"volunteers.":[96],"In":[97,115],"part":[98,116],"I":[99],"study,":[102],"subjects":[103],"received":[104],"single":[105],"rising":[106],"i.v.":[107,133],"up":[110],"8":[112],"g":[113,124,127],"Fab.":[114],"II,":[117],"1":[121],"g,":[122],"2":[123],"4":[126,144],"administered":[129],"as":[130,152],"5":[131],"min":[132],"infusion":[134],"presence":[137],"(220":[140],"mg":[141],"bid":[142],"days).":[145],"Concentrations":[146],"unbound":[148],"measure":[154],"pharmacologically":[156],"ac...":[157]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":25},{"year":2014,"cited_by_count":12}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}